Brief: Cstone Pharmaceuticals Says FY Loss Rmb1,920.1 Mln Versus Loss Rmb1,221.0 Mln
31/05/2022 15:55
May 31 (Reuters) - CStone Pharmaceuticals 2616.HK :
* FY LOSS RMB1,920.1 MILLION VERSUS LOSS RMB1,221.0 MILLION
* FY REVENUE RMB243.7 MILLION VERSUS RMB1.04 BILLION
Further company coverage: 2616.HK
Recent news on CStone Pharmaceuticals
See all newsBrief: CStone Pharmaceuticals Says CEO Purchases 496,000 Shares For Over HK$2.7 Million From Sept 17-22
Brief: CStone Pharmaceuticals Posts HY Loss Of Rmb252.3 Million
China's CStone Pharmaceuticals H1 revenue soars on drug sales
Brief: Cstone Pharmaceuticals Receives NMPA IND Approval For CS5007 In China
Brief: CStone Pharmaceuticals Says Directors And Senior Management Purchase 2.4 Million Shares In June 2026